Regulation of Dipeptidyl Peptidase IV in the Post-stroke Rat Brain and In Vitro Ischemia: Implications for Chemokine-Mediated Neural Progenitor Cell Migration and Angiogenesis

Molecular Neurobiology

Volumn 54, Issue 7, 2017, Pages 4973-4985

  Wesley, Umadevi V ^a   Hatcher, James F ^a   Ayvaci, Emine R ^a   Klemp, Abby ^a   Dempsey, Robert J ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Angiogenesis; Dipeptidyl peptidase IV; Ischemic brain injury; Migration; Neural progenitor cells; Stromal derived factor

Indexed keywords

BETA ACTIN; DIPEPTIDYL PEPTIDASE IV; GELATINASE B; MICROTUBULE ASSOCIATED PROTEIN 2; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN KINASE B; STROMAL CELL DERIVED FACTOR 1; DPP4 PROTEIN, RAT;

ADULT; ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN ISCHEMIA; CELL MIGRATION; CELL REGENERATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; IMMUNOREACTIVITY; IN VITRO STUDY; MALE; NERVE CELL DIFFERENTIATION; NEURAL STEM CELL; NEUROPATHOLOGY; NONHUMAN; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; UPREGULATION; ANIMAL; BRAIN; CELL MOTION; CEREBROVASCULAR ACCIDENT; DRUG EFFECT; ENZYMOLOGY; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); NERVOUS SYSTEM DEVELOPMENT; PATHOLOGY; PHYSIOLOGY;

ANIMALS; BRAIN; BRAIN ISCHEMIA; CELL MOVEMENT; DIPEPTIDYL PEPTIDASE 4; ENDOTHELIAL CELLS; MALE; NEOVASCULARIZATION, PATHOLOGIC; NEURAL STEM CELLS; NEUROGENESIS; RATS; STROKE;

EID: 84982144199     PISSN: 08937648     EISSN: 15591182     Source Type: Journal    
DOI: 10.1007/s12035-016-0039-4     Document Type: Article

References (79)

1. Arai K, Lok J, Guo S, Hayakawa K, Xing C, Lo EH (2011) Cellular mechanisms of neurovascular damage and repair after stroke. J Child Neurol 26(9):1193–1198. doi:10.1177/0883073811408610
2. Lee SR, Wang X, Tsuji K, Lo EH (2004) Extracellular proteolytic pathophysiology in the neurovascular unit after stroke. Neurol Res 26(8):854–861. doi:10.1179/016164104X3806
3. Lo EH (2008) A new penumbra: transitioning from injury into repair after stroke. Nat Med 14(5):497–500. doi:10.1038/nm1735
4. Love S (2003) Apoptosis and brain ischaemia. Prog Neuro-Psychopharmacol Biol Psychiatry 27(2):267–282. doi:10.1016/S0278-5846(03)00022-8
5. Moskowitz MA, Lo EH, Iadecola C (2010) The science of stroke: mechanisms in search of treatments. Neuron 67(2):181–198. doi:10.1016/j.neuron.2010.07.002
6. Vivien D, Buisson A (2000) Serine protease inhibitors: novel therapeutic targets for stroke? J Cereb Blood Flow Metab 20(5):755–764. doi:10.1097/00004647-200005000-00001
7. Wang X, Li X, Xu L, Zhan Y, Yaish-Ohad S, Erhardt JA, Barone FC, Feuerstein GZ (2003) Up-regulation of secretory leukocyte protease inhibitor (SLPI) in the brain after ischemic stroke: adenoviral expression of SLPI protects brain from ischemic injury. Mol Pharmacol 64(4):833–840. doi:10.1124/mol.64.4.833
8. Arvidsson A, Collin T, Kirik D, Kokaia Z, Lindvall O (2002) Neuronal replacement from endogenous precursors in the adult brain after stroke. Nat Med 8(9):963–970. doi:10.1038/nm747
9. Chang YC, Shyu WC, Lin SZ, Li H (2007) Regenerative therapy for stroke. Cell Transplant 16(2):171–181
10. Jin K, Sun Y, Xie L, Peel A, Mao XO, Batteur S, Greenberg DA (2003) Directed migration of neuronal precursors into the ischemic cerebral cortex and striatum. Mol Cell Neurosci 24(1):171–189
11. Kalluri HS, Dempsey RJ (2008) Growth factors, stem cells, and stroke. Neurosurg Focus 24(3–4):E14. doi:10.3171/FOC/2008/24/3-4/E13
12. Ohab JJ, Fleming S, Blesch A, Carmichael ST (2006) A neurovascular niche for neurogenesis after stroke. J Neurosci 26(50):13007–13016. doi:10.1523/JNEUROSCI.4323-06.2006
13. Segarra M, Kirchmaier BC, Acker-Palmer A (2015) A vascular perspective on neuronal migration. Mech Dev 138(Pt 1):17–25. doi:10.1016/j.mod.2015.07.004
14. Xiong Y, Mahmood A, Chopp M (2010) Angiogenesis, neurogenesis and brain recovery of function following injury. Curr Opin Investig Drugs 11(3):298–308
15. Yamashita T, Ninomiya M, Hernandez Acosta P, Garcia-Verdugo JM, Sunabori T, Sakaguchi M, Adachi K, Kojima T, Hirota Y, Kawase T, Araki N, Abe K, Okano H, Sawamoto K (2006) Subventricular zone-derived neuroblasts migrate and differentiate into mature neurons in the post-stroke adult striatum. J Neurosci 26(24):6627–6636. doi:10.1523/JNEUROSCI.0149-06.2006
16. Bosisio D, Salvi V, Gagliostro V, Sozzani S (2014) Angiogenic and antiangiogenic chemokines. Chem Immunol Allergy 99:89–104. doi:10.1159/000353317
17. Wang B, Jin K (2015) Current perspectives on the link between neuroinflammation and neurogenesis. Metab Brain Dis 30(2):355–365. doi:10.1007/s11011-014-9523-6
18. Shyu WC, Lee YJ, Liu DD, Lin SZ, Li H (2006) Homing genes, cell therapy and stroke. Front Biosci 11:899–907
19. Sozzani S, Del Prete A, Bonecchi R, Locati M (2015) Chemokines as effector and target molecules in vascular biology. Cardiovasc Res 107(3):364–372. doi:10.1093/cvr/cvv150
20. Yan YP, Sailor KA, Lang BT, Park SW, Vemuganti R, Dempsey RJ (2007) Monocyte chemoattractant protein-1 plays a critical role in neuroblast migration after focal cerebral ischemia. J Cereb Blood Flow Metab 27(6):1213–1224. doi:10.1038/sj.jcbfm.9600432
21. Bakondi B, Shimada IS, Peterson BM, Spees JL (2011) SDF-1alpha secreted by human CD133-derived multipotent stromal cells promotes neural progenitor cell survival through CXCR7. Stem Cells Dev 20(6):1021–1029. doi:10.1089/scd.2010.0198
22. Ceradini DJ, Kulkarni AR, Callaghan MJ, Tepper OM, Bastidas N, Kleinman ME, Capla JM, Galiano RD, Levine JP, Gurtner GC (2004) Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med 10(8):858–864. doi:10.1038/nm1075
23. Cui L, Qu H, Xiao T, Zhao M, Jolkkonen J, Zhao C (2013) Stromal cell-derived factor-1 and its receptor CXCR4 in adult neurogenesis after cerebral ischemia. Restor Neurol Neurosci 31(3):239–251. doi:10.3233/RNN-120271
24. Filippo TR, Galindo LT, Barnabe GF, Ariza CB, Mello LE, Juliano MA, Juliano L, Porcionatto MA (2013) CXCL12 N-terminal end is sufficient to induce chemotaxis and proliferation of neural stem/progenitor cells. Stem Cell Res 11(2):913–925. doi:10.1016/j.scr.2013.06.003
25. Nagasawa T (2015) CXCL12/SDF-1 and CXCR4. Front Immunol 6:301. doi:10.3389/fimmu.2015.00301
26. Wang Y, Huang J, Li Y, Yang GY (2012) Roles of chemokine CXCL12 and its receptors in ischemic stroke. Curr Drug Targets 13(2):166–172
27. Imitola J, Raddassi K, Park KI, Mueller FJ, Nieto M, Teng YD, Frenkel D, Li J, Sidman RL, Walsh CA, Snyder EY, Khoury SJ (2004) Directed migration of neural stem cells to sites of CNS injury by the stromal cell-derived factor 1alpha/CXC chemokine receptor 4 pathway. Proc Natl Acad Sci U S A 101(52):18117–18122. doi:10.1073/pnas.0408258102
28. Merino JJ, Bellver-Landete V, Oset-Gasque MJ, Cubelos B (2015) CXCR4/CXCR7 molecular involvement in neuronal and neural progenitor migration: focus in CNS repair. J Cell Physiol 230(1):27–42. doi:10.1002/jcp.24695
29. Robin AM, Zhang ZG, Wang L, Zhang RL, Katakowski M, Zhang L, Wang Y, Zhang C, Chopp M (2006) Stromal cell-derived factor 1alpha mediates neural progenitor cell motility after focal cerebral ischemia. J Cereb Blood Flow Metab 26(1):125–134. doi:10.1038/sj.jcbfm.9600172
30. Yin W, Ma L, Zhang J, Huang K, Yang Q, Guo YY, Liu SB, Liu YH, Wu YM (2013) The migration of neural progenitor cell mediated by SDF-1 is NF-kappaB/HIF-1alpha dependent upon hypoxia. CNS Neurosci Ther 19(3):145–153. doi:10.1111/cns.12049
31. Kurzepa J, Kurzepa J, Golab P, Czerska S, Bielewicz J (2014) The significance of matrix metalloproteinase (MMP)-2 and MMP-9 in the ischemic stroke. Int J Neurosci 124(10):707–716. doi:10.3109/00207454.2013.872102
32. Yang Y, Rosenberg GA (2015) Matrix metalloproteinases as therapeutic targets for stroke. Brain Res. doi:10.1016/j.brainres.2015.04.024
33. Zhao BQ, Wang S, Kim HY, Storrie H, Rosen BR, Mooney DJ, Wang X, Lo EH (2006) Role of matrix metalloproteinases in delayed cortical responses after stroke. Nat Med 12(4):441–445. doi:10.1038/nm1387
34. Boonacker E, Van Noorden CJ (2003) The multifunctional or moonlighting protein CD26/DPPIV. Eur J Cell Biol 82(2):53–73. doi:10.1078/0171-9335-00302
35. Christopherson KW 2nd, Hangoc G, Broxmeyer HE (2002) Cell surface peptidase CD26/dipeptidylpeptidase IV regulates CXCL12/stromal cell-derived factor-1 alpha-mediated chemotaxis of human cord blood CD34+ progenitor cells. J Immunol 169(12):7000–7008
36. Ou X, O’Leary HA, Broxmeyer HE (2013) Implications of DPP4 modification of proteins that regulate stem/progenitor and more mature cell types. Blood 122(2):161–169. doi:10.1182/blood-2013-02-487470
37. Wesley UV, Albino AP, Tiwari S, Houghton AN (1999) A role for dipeptidyl peptidase IV in suppressing the malignant phenotype of melanocytic cells. J Exp Med 190(3):311–322
38. Wesley UV, McGroarty M, Homoyouni A (2005) Dipeptidyl peptidase inhibits malignant phenotype of prostate cancer cells by blocking basic fibroblast growth factor signaling pathway. Cancer Res 65(4):1325–1334. doi:10.1158/0008-5472.CAN-04-1852
39. Arscott WT, LaBauve AE, May V, Wesley UV (2009) Suppression of neuroblastoma growth by dipeptidyl peptidase IV: relevance of chemokine regulation and caspase activation. Oncogene 28(4):479–491. doi:10.1038/onc.2008.402
40. Sun YX, Pedersen EA, Shiozawa Y, Havens AM, Jung Y, Wang J, Pienta KJ, Taichman RS (2008) CD26/dipeptidyl peptidase IV regulates prostate cancer metastasis by degrading SDF-1/CXCL12. Clin Exp Metastasis 25(7):765–776. doi:10.1007/s10585-008-9188-9
41. Jungraithmayr W, De Meester I, Matheeussen V, Baerts L, Arni S, Weder W (2012) CD26/DPP-4 inhibition recruits regenerative stem cells via stromal cell-derived factor-1 and beneficially influences ischaemia-reperfusion injury in mouse lung transplantation. Eur J Cardiothorac Surg 41(5):1166–1173. doi:10.1093/ejcts/ezr180
42. Rohnert P, Schmidt W, Emmerlich P, Goihl A, Wrenger S, Bank U, Nordhoff K, Tager M, Ansorge S, Reinhold D, Striggow F (2012) Dipeptidyl peptidase IV, aminopeptidase N and DPIV/APN-like proteases in cerebral ischemia. J Neuroinflammation 9:44
43. Chua S, Sheu JJ, Chen YL, Chang LT, Sun CK, Leu S, Sung HC, Tsai TH, Chung SY, Yeh KH, Cho CL, Kao YH, Yip HK (2013) Sitagliptin therapy enhances the number of circulating angiogenic cells and angiogenesis—evaluations in vitro and in the rat critical limb ischemia model. Cytotherapy 15(9):1148–1163. doi:10.1016/j.jcyt.2013.05.005
44. Vaghasiya J, Sheth N, Bhalodia Y, Manek R (2011) Sitagliptin protects renal ischemia reperfusion induced renal damage in diabetes. Regul Pept 166(1–3):48–54. doi:10.1016/j.regpep.2010.08.007
45. Chua S, Lee FY, Tsai TH, Sheu JJ, Leu S, Sun CK, Chen YL, Chang HW, Chai HT, Liu CF, Lu HI, Yip HK (2014) Inhibition of dipeptidyl peptidase-IV enzyme activity protects against myocardial ischemia-reperfusion injury in rats. J Transl Med 12:357. doi:10.1186/s12967-014-0357-0
46. Zhong J, Maiseyeu A, Davis SN, Rajagopalan S (2015) DPP4 in cardiometabolic disease: recent insights from the laboratory and clinical trials of DPP4 inhibition. Circ Res 116(8):1491–1504. doi:10.1161/CIRCRESAHA.116.305665
47. Zhong J, Rao X, Rajagopalan S (2013) An emerging role of dipeptidyl peptidase 4 (DPP4) beyond glucose control: potential implications in cardiovascular disease. Atherosclerosis 226(2):305–314
48. Dempsey RJ, Sailor KA, Bowen KK, Tureyen K, Vemuganti R (2003) Stroke-induced progenitor cell proliferation in adult spontaneously hypertensive rat brain: effect of exogenous IGF-1 and GDNF. J Neurochem 87(3):586–597
49. Kalluri HS, Vemuganti R, Dempsey RJ (2007) Mechanism of insulin-like growth factor I-mediated proliferation of adult neural progenitor cells: role of Akt. Eur J Neurosci 25(4):1041–1048. doi:10.1111/j.1460-9568.2007.05336.x
50. George PM, Steinberg GK (2015) Novel stroke therapeutics: unraveling stroke pathophysiology and its impact on clinical treatments. Neuron 87(2):297–309. doi:10.1016/j.neuron.2015.05.041
51. Kahle MP, Bix GJ (2013) Neuronal restoration following ischemic stroke: influences, barriers, and therapeutic potential. Neurorehabil Neural Repair 27(5):469–478. doi:10.1177/1545968312474119
52. Kahle MP, Bix GJ (2012) Successfully climbing the “STAIRs”: surmounting failed translation of experimental ischemic stroke treatments. Stroke Res Treat 2012:374098. doi:10.1155/2012/374098
53. Candelario-Jalil E (2009) Injury and repair mechanisms in ischemic stroke: considerations for the development of novel neurotherapeutics. Curr Opin Investig Drugs 10(7):644–654
54. Rudolph M (1989) Determination of saterinone in plasma by high-performance liquid chromatography. J Chromatogr 497:342–348
55. Zhao BQ, Chauhan AK, Canault M, Patten IS, Yang JJ, Dockal M, Scheiflinger F, Wagner DD (2009) Von Willebrand factor-cleaving protease ADAMTS13 reduces ischemic brain injury in experimental stroke. Blood 114(15):3329–3334. doi:10.1182/blood-2009-03-213264
56. Fadini GP, Avogaro A (2013) Dipeptidyl peptidase-4 inhibition and vascular repair by mobilization of endogenous stem cells in diabetes and beyond. Atherosclerosis 229(1):23–29. doi:10.1016/j.atherosclerosis.2013.04.007
57. Mortier A, Gouwy M, Van Damme J, Proost P (2011) Effect of posttranslational processing on the in vitro and in vivo activity of chemokines. Exp Cell Res 317(5):642–654. doi:10.1016/j.yexcr.2010.11.016
58. Scharpe S, De Meester I (2001) Peptide truncation by dipeptidyl peptidase IV: a new pathway for drug discovery? Verh K Acad Geneeskd Belg 63(1):5–32 discussion 32-33
59. Wolf M, Albrecht S, Marki C (2008) Proteolytic processing of chemokines: implications in physiological and pathological conditions. Int J Biochem Cell Biol 40(6–7):1185–1198. doi:10.1016/j.biocel.2007.12.009
60. Lo EH, Broderick JP, Moskowitz MA (2004) tPA and proteolysis in the neurovascular unit. Stroke 35(2):354–356. doi:10.1161/01.STR.0000115164.80010.8A
61. Niego B, Medcalf RL (2014) Plasmin-dependent modulation of the blood-brain barrier: a major consideration during tPA-induced thrombolysis? J Cereb Blood Flow Metab 34(8):1283–1296. doi:10.1038/jcbfm.2014.99
62. van Hinsbergh VW, Koolwijk P, Hanemaaijer R (1997) Role of fibrin and plasminogen activators in repair-associated angiogenesis: in vitro studies with human endothelial cells. EXS 79:391–411
63. Wesley UV, Tiwari S, Houghton AN (2004) Role for dipeptidyl peptidase IV in tumor suppression of human non small cell lung carcinoma cells. Int J Cancer 109(6):855–866. doi:10.1002/ijc.20091
64. Lee B, Clarke D, Al Ahmad A, Kahle M, Parham C, Auckland L, Shaw C, Fidanboylu M, Orr AW, Ogunshola O, Fertala A, Thomas SA, Bix GJ (2011) Perlecan domain V is neuroprotective and proangiogenic following ischemic stroke in rodents. J Clin Invest 121(8):3005–3023
65. Zhang RL, Zhang ZG, Chopp M (2008) Ischemic stroke and neurogenesis in the subventricular zone. Neuropharmacology 55(3):345–352. doi:10.1016/j.neuropharm.2008.05.027
66. Gu N, Tsuda M, Matsunaga T, Adachi T, Yasuda K, Ishihara A, Tsuda K (2008) Glucose regulation of dipeptidyl peptidase IV gene expression is mediated by hepatocyte nuclear factor-1alpha in epithelial intestinal cells. Clin Exp Pharmacol Physiol 35(12):1433–1439
67. Rohrborn D, Eckel J, Sell H (2014) Shedding of dipeptidyl peptidase 4 is mediated by metalloproteases and up-regulated by hypoxia in human adipocytes and smooth muscle cells. FEBS Lett 588(21):3870–3877
68. Tilan JU, Lu C, Galli S, Izycka-Swieszewska E, Earnest JP, Shabbir A, Everhart LM, Wang S, Martin S, Horton M, Mahajan A, Christian D, O’Neill A, Wang H, Zhuang T, Czarnecka M, Johnson MD, Toretsky JA, Kitlinska J (2013) Hypoxia shifts activity of neuropeptide Y in Ewing sarcoma from growth-inhibitory to growth-promoting effects. Oncotarget 4(12):2487–2501
69. Proost P, Struyf S, Schols D, Durinx C, Wuyts A, Lenaerts JP, De Clercq E, De Meester I, Van Damme J (1998) Processing by CD26/dipeptidyl-peptidase IV reduces the chemotactic and anti-HIV-1 activity of stromal-cell-derived factor-1alpha. FEBS Lett 432(1–2):73–76
70. El-Sahar AE, Safar MM, Zaki HF, Attia AS, Ain-Shoka AA (2015) Sitagliptin attenuates transient cerebral ischemia/reperfusion injury in diabetic rats: implication of the oxidative-inflammatory-apoptotic pathway. Life Sci 126:81–86. doi:10.1016/j.lfs.2015.01.030
71. Bajetto A, Barbero S, Bonavia R, Piccioli P, Pirani P, Florio T, Schettini G (2001) Stromal cell-derived factor-1alpha induces astrocyte proliferation through the activation of extracellular signal-regulated kinases 1/2 pathway. J Neurochem 77(5):1226–1236
72. Bonavia R, Bajetto A, Barbero S, Pirani P, Florio T, Schettini G (2003) Chemokines and their receptors in the CNS: expression of CXCL12/SDF-1 and CXCR4 and their role in astrocyte proliferation. Toxicol Lett 139(2–3):181–189
73. Dilly AK, Ekambaram P, Guo Y, Cai Y, Tucker SC, Fridman R, Kandouz M, Honn KV (2013) Platelet-type 12-lipoxygenase induces MMP9 expression and cellular invasion via activation of PI3K/Akt/NF-kappaB. Int J Cancer 133(8):1784–1791. doi:10.1002/ijc.28165
74. Lin F, Chengyao X, Qingchang L, Qianze D, Enhua W, Yan W (2015) CRKL promotes lung cancer cell invasion through ERK-MMP9 pathway. Mol Carcinog 54(Suppl 1):E35–E44. doi:10.1002/mc.22148
75. Yao C, Li P, Song H, Song F, Qu Y, Ma X, Shi R, Wu J (2015) CXCL12/CXCR4 axis upregulates twist to induce EMT in human glioblastoma. [published online ahead of print July 16, 2015] Mol Neurobiol. doi:10.1007/s12035-015-9340-x
76. Zheng H, Fu G, Dai T, Huang H (2007) Migration of endothelial progenitor cells mediated by stromal cell-derived factor-1alpha/CXCR4 via PI3K/Akt/eNOS signal transduction pathway. J Cardiovasc Pharmacol 50(3):274–280. doi:10.1097/FJC.0b013e318093ec8f
77. Wang L, Zhang ZG, Zhang RL, Gregg SR, Hozeska-Solgot A, LeTourneau Y, Wang Y, Chopp M (2006) Matrix metalloproteinase 2 (MMP2) and MMP9 secreted by erythropoietin-activated endothelial cells promote neural progenitor cell migration. J Neurosci 26(22):5996–6003. doi:10.1523/JNEUROSCI.5380-05.2006
78. Tang SK, Knobloch RA, Maucksch C, Connor B (2014) Redirection of doublecortin-positive cell migration by over-expression of the chemokines MCP-1, MIP-1alpha and GRO-alpha in the adult rat brain. Neuroscience 260:240–248. doi:10.1016/j.neuroscience.2013.12.022
79. Havre PA, Abe M, Urasaki Y, Ohnuma K, Morimoto C, Dang NH (2008) The role of CD26/dipeptidyl peptidase IV in cancer. Front Biosci 13:1634–1645